$RFL News Article - Rafael Pharmaceuticals Crosses
Post# of 144482
(Total Views: 159)
Posted On: 07/21/2020 1:15:47 PM
$RFL News Article - Rafael Pharmaceuticals Crosses Midpoint of Enrollment to First Interim Analysis in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/rafa...37943.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼